Lecture Notes

**Lecture Coverage:**
- Mechanisms of Hypertension
- RAA System Drugs
- Adrenoceptor Drugs
- Ion Channel Drugs
- Diuretics
- Vasodilators

---
#### **Mechanisms of Hypertension**
- Cardiovascular Dysfunction
	- ↑ <abbr Title="Cardiac Output">CO</abbr>: ↑ <abbr Title="Stroke Volume">SV</abbr> / <abbr Title="Heart Rate">HR</abbr>
	- ↑ Peripheral Vascular Resistance: Impaired Vasodilation / Atherosclerosis
- Hormonal Dysregulation
	- RAA System
		- Angiotensin II: Vasoconstriction, ↑ Aldosterone Secretion & Sympathetic Tone
		- Aldosterone: ↑ Na<sup>+</sup> & Water Reabsorption → Fluid Retention
- Neural Dysregulation
	- ↑ Sympathetic Tone from Stress / Angiotensin II
- Other Factors
	- Lifestyle: Diet & Obesity
	- Genetic: Family History


#### **RAA System Drugs**
- Aim: ↓ Lowers Angiotensin II Activity
	- ACE Inhibitors
	- Angiotensin II Type 1 Receptor Antagonists

**Angiotensin Converting Enzyme (ACE) Inhibitors**
- Suffix: -pril (e.g. Benazepril, Captopril, Cilazapril)
- Mechanism:

| Step  | Event            | Effect                                               |
| ----- | ---------------- | ---------------------------------------------------- |
| 1     | ACE Inhibition   | ↓ Angiotensin I to II Conversion                     |
| <br>2 | ↓ Angiotensin II | Vasodilation<br>↓ Aldosterone & Sympathetic Activity |
| ^     | ↑ Bradykinin     | Vasodilation                                         |
| 3     | ↓ Aldosterone    | ↓ Na<sup>+</sup> & Water Reabsorption                |
- Site of Action & Elimination
	- Action: Heart, Blood Vessels, Brain, Adrenal Glands & Kidney
	- Elimination: Liver & Kidney

**Angiotensin II Receptor Antagonists**
- Suffix: -sartan (e.g. Losartan, Telmisartan, Valsartan)
- Mechanism:

| Step | Event           | Description                                                                    |
| ---- | --------------- | ------------------------------------------------------------------------------ |
| 1    | AT1R Inhibition | Selective Blockage of <abbr Title="Angiotensin II Type 1 Receptor">AT1R</abbr> |
| 2    | ↓ AT1R Effect   | Vasodilation <br>↓ Aldosterone & Sympathetic Activity                          |
| 3    | ↓ Aldosterone   | ↓ Na<sup>+</sup> & Water Reabsorption                                          |
- Site of Action & Elimination
	- Action: Heart, Blood Vessels & Kidney
	- Elimination: Liver (Biliary) & Kidney

#### **Adrenoceptor Drugs**
- Aim: Lower Sympathetic Tone
	- α1 & β Blockers ([[Lecture 5.3A - (Synaptic Pharmacology) Adrenergic Receptor & Synaptic Drugs#**Classification of Adrenoceptors**|Details]])
	- α2 Agonists

**α1 Blockers**
- Suffix: -zosin (e.g. Prazosin, Terazosin & Doxazosin)
- Mechanisms:

| Step | Event              | Effect                                          |
| ---- | ------------------ | ----------------------------------------------- |
| 1    | α1 Blockage        | ↓ α1 Activation by Noradrenaline                |
| 2    | ↓ Vasoconstriction | Vasodilation & ↓ Peripheral Vascular Resistance |

**α2 Agonists**
- Suffix: -idine (e.g. Clonidine, Rilmenidine)
	- Exception: Methyldopa
- Mechanisms:

| Step | Event              | Effect                                               |
| ---- | ------------------ | ---------------------------------------------------- |
| 1    | α2 Activation      | ↓ Noradrenaline Exocytosis from Preganglionic Neuron |
| 2    | ↓ Sympathetic Tone | ↓ HR                                                 |

**β Blockers**
- Main Effect: Blocks β1 Receptors
- Suffix: -olol

|          Rule          | Meaning                             | Examples                             | Additional Effects                                                            |
| :--------------------: | ----------------------------------- | ------------------------------------ | ----------------------------------------------------------------------------- |
|  <br>Starts with A-M   | <br>More Cardioselective β Blockers | Atenolol<br>Bisoprolol<br>Metoprolol |                                                                               |
|    Starts with N-Z     | Non-Selective β Blockers            | Nebivolol<br>Propranolol             | Causes <abbr Title="Dangerous for Asthma Patients">Bronchoconstriction</abbr> |
| Doesn't end with -olol | α & β Blockers                      | Carvedilol                           | α1 Antagonism: Causes Vasodilation                                            |
- Mechanisms:

| Step | Event                        | Effect         |
| ---- | ---------------------------- | -------------- |
| 1    | β1 Blockage                  |                |
| 2    | ↓ Renin Release              | ↓ RAA Activity |
| ^    | ↓ Heart Rate & Contractility | ↓ CO           |


#### **Ion Channel Drugs**
- Aim: ↓ Lowers Ca<sup>2+</sup> Influx → ↓ Cardiac & Smooth Muscle Contractility
	- <abbr Title="Calcium Channel Blockers">CCB</abbr>
	- Potassium Channel Openers
- Ca<sup>2+</sup> Role in Muscle Contraction:

| Step | Event                                                            |
| ---- | ---------------------------------------------------------------- |
| 1    | Changes Tropomyosin conformation                                 |
| 2    | Myosin detach from Tropomyosin & binds to Actin temporarily (出軌) |
| 3    | Muscle Contraction                                               |

**Calcium Channel Blockers (CCB)**
- Suffix: -dipine (e.g. Nifedipine, Lercanidipine, Felodipine)
- Mechanisms:

| Step  | Event                                         | Effect                      |
| ----- | --------------------------------------------- | --------------------------- |
| 1     | Voltage-Gated L Type Calcium Channel Blockage | ↓ Ca<sup>2+</sup> Influx    |
| <br>2 | ↓ Smooth Muscle Contractility                 | Vasodilation                |
| ^     | ↓ Cardiac Muscle Contractility                | ↓ CO & O<sub>2</sub> Demand |
- Site of Action & Elimination:
	- Action: Heart & Arteries
	- Elimination: Kidney

**Potassium Channel Opener**
- Suffix: -dil (e.g. Minoxidil, Pinacidil, Nicorandil)
	- Exception: Diazoxide
- Used when other medication with no effect
	- Given with Diuretics & β Blockers
- Mechanisms:

| Step  | Event                                                                                   | Effect                                       |
| ----- | --------------------------------------------------------------------------------------- | -------------------------------------------- |
| 1     | K<sub>ATP</sub> Opening                                                                 | ↑ K<sup>+</sup> Efflux → ↑ Hyperpolarization |
| 2     | <abbr Title="Opens only in Depolarization">Voltage-Gated</abbr> Calcium Channel Closure | ↓ Ca<sup>2+</sup> Influx                     |
| <br>3 | ↓ Smooth Muscle Contractility                                                           | Vasodilation                                 |
| ^     | ↓ Cardiac Muscle Contractility                                                          | ↓ CO & O<sub>2</sub> Demand                  |


#### **Diuretics**
- Categorized by Sites of Action

|                Type                 |                                  <                                  |           Name           | Site of Action                      |
| :---------------------------------: | :-----------------------------------------------------------------: | :----------------------: | ----------------------------------- |
|           Loop Diuretics            | Na<sup>+</sup>/K<sup>+</sup>/2Cl<sup>-</sup> Co-transporter Blocker |        Furosemide        | Ascending Loop of Henle             |
|         Thiazide Diuretics          |           Na<sup>+</sup>/Cl<sup>-</sup> Symporter Blocker           |   Hydrochlorothiazide    | Distal Tubule                       |
| <br>K<sup>+</sup>-Sparing Diuretics |    <abbr Title="Epithelial Sodium Channel">ENaC</abbr> Inhibitor    | Triamterene<br>Amiloride | <br>Distal Tubule & Collecting Duct |
|                  ^                  |                       Aldosterone Antagonist                        |      Spironolactone      | ^                                   |
- Aim: ↑ Urine Volume → ↓ Water Retention & Blood Volume
	- Mechanisms:

| Step | Event                              | Effect                                     |
| ---- | ---------------------------------- | ------------------------------------------ |
| 1    | Ion Transporter Blockage           | ↓ Ion (Mainly Na<sup>+</sup>) Reabsorption |
| 2    | Interstitium Osmolality < Filtrate | ↓ Water Reabsorption                       |
| 3    | ↑ Urine Volume                     | ↓ Water Retention & Blood Volume           |


**Loop Diuretics (Furosemide)**
- Na<sup>+</sup>/K<sup>+</sup>/2Cl<sup>-</sup> Co-transporter Blocker
	- Also ↓ K<sup>+</sup> Reabsorption → Hypokalemia
	- Also ↓ Cl<sup>-</sup>, Mg<sup>2+</sup> Reabsorption
	- ↑ Ca<sup>2+</sup> Reabsorption

**Thiazide Diuretics (Hydrochlorothiazide)**
- Na<sup>+</sup>/Cl<sup>-</sup> Symporter Blocker
	- Also ↓ K<sup>+</sup> Reabsorption → Hypokalemia
	- Also ↓ Cl<sup>-</sup>, Mg<sup>2+</sup> & Ca<sup>2+</sup> Reabsorption

**Potassium Sparing Diuretics**
- ENaC Inhibitors (Triamterene & Amiloride) / Aldosterone Antagonist (Spironolactone)
	- No Effect on K<sup>+</sup> Reabsorption


#### **Vasodilators**
- Used when other medications have no effect
	- Given with Diuretics & β Blockers
- Aim: ↑ Nitric Oxide → ↑ cGMP → Vasodilation:

| Step | Event                    | Effect                           |
| ---- | ------------------------ | -------------------------------- |
| 1    | ↑ Nitric Oxide from Drug | ↑ GTP → cGMP by Guanylyl Cyclase |
| 2    | ↑ cGMP                   | Vasodilation                     |

**Types of Vasodilators**
- Nitroprusside
	- Both Arterial & Venous Vasodilation
	- Directly Converts into Nitric Oxide in the body
- Hydralazine
	- Arterial Vasodilation
	- Side Effect: Long term usage leads to ↑ Renin release
